Lars Leibrock

Federal Institute for Risk Assessment

Papers

2

Total Citations

78

H-Index

2

About

Dr. Lars Leibrock is a leading figure in the field of **inhalation toxicology**, with a specific focus on developing advanced **in vitro models** to assess respiratory hazards. His major contribution lies in pioneering the application of **organ-on-a-chip** technologies and soft robotics-inspired design to create more physiologically relevant systems for studying how airborne pollutants and viruses affect human lung tissue. His most cited work, "Emerging Technologies for In Vitro Inhalation Toxicology" (2021), has garnered **70 citations**, establishing it as a cornerstone reference in the field. This comprehensive review systematically evaluates the bottlenecks and advantages of current in vitro platforms, addressing the urgent need for better models in a world where airborne viral infections and pollutant inhalation cause over **2 million annual morbidities**. Dr. Leibrock’s research is critical for bridging the gap between clinical epidemiology and laboratory science, providing tools that can predict human responses to inhaled contaminants more accurately than traditional methods, thereby advancing both drug development and public health safety.

Research Focus

Key Achievements

2
H-Index
2
Papers
78
Total Citations
39
Avg Citations/Paper
🏆 Most Cited Paper
Emerging Technologies for In Vitro Inhalation Toxicology
70 citations · 2021
📈 Most Prolific Year: 2021 (2 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Federal Institute for Risk Assessment

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago